▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Sherwin-Williams Q3 22 Earnings Conference Call At 11;00 AM ET

By RTTNews Staff Writer ✉ | Published: 10/25/2022 10:00 AM ET

Sherwin-Williams Co. (SHW) will host a conference call at 11:00 AM ET on October 25, 2022, to discuss Q3 22 earnings results.

To access the live webcast, log on to https://investors.sherwin-williams.com/financials/quarterly-results/

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech stocks Facing FDA Decision in January 2023

Latest Updates on COVID-19

34% Fall In US Covid Cases, 38% Fall In Deaths In Last 2 Weeks

Biden Signs Covid Origins Bill Into Law

FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5

Covid Cases, Hospitalizations Fall Nationwide In Last 2 Weeks

FDA Authorizes First At-Home Test To Detect Flu And COVID-19

Read More

COVID-19: Drugs in Development

RELATED NEWS

Sherwin-Williams Slides After Unexciting FY23 Guidance

Sherwin-Williams Co Q4 22 Earnings Conference Call At 11:00 AM ET

Sherwin-Williams Co Q4 Profit Increases, beats estimates

Follow RTT

Editor's Pick
Most Read
Most Emailed

United Airlines, Archer To Launch First Air Taxi Route In Chicago

Aunt Millie's Our Family White Hot Dog Buns Recalled

Ascend Labs Recalls Oral Anticoagulant Dabigatran Etexilate Capsules

FDA Clears Eat Just's Good Meat Cultivated Chicken

Attorneys General Of 23 US States Urge Hyundai, Kia To Take Swift Action Against Car Thefts

Kagome Worcester, Chuno, Take Out Tonkatsu Sauces Recalled

Domino's Offering 50% Off Menu-Priced Pizzas Through March 26

FDA Bans 2 Vuse Solo Menthol E-cigarette Products

Foot Locker Q4 Profit Down, Warns On FY23; To Close Hong Kong Operations

Hoyo, SBC Recalls Frozen, Ready-To-Eat Beef Sambusa Product

Mockingbird Expands Recall To Include Single Strollers

Novartis: SMA Drug Zolgensma Long-term Data Shows Sustained Durability Up To 7.5 Years Post-dosing

Accenture Sees Higher Q3 Revenues; Cuts FY23 Earnings, Sales Growth View - Update

FDA Clears Eat Just's Good Meat Cultivated Chicken

Pearson In Deal To Sell Pearson Online Learning Services To Regent

Foot Locker Q4 Profit Down, Warns On FY23; To Close Hong Kong Operations

Zai Lab Partner Karuna's Phase 3 Trial Of KarXT In Schizophrenia Meets Primary Endpoint

Knight-Swift To Acquire U.S. Xpress Enterprises For Enterprise Value Of $808 Mln

PDD Holdings Q4 Profit Rises 43%

Sandoz Gets FDA Approval For Biosimilar Hyrimoz High-concentration Formulation

89bio: Phase 2b ENLIVEN Trial Of Pegozafermin In Patients With NASH Meets Primary Goals

Ascend Labs Recalls Oral Anticoagulant Dabigatran Etexilate Capsules

FDA Bans 2 Vuse Solo Menthol E-cigarette Products

Novartis: SMA Drug Zolgensma Long-term Data Shows Sustained Durability Up To 7.5 Years Post-dosing

Mortgage Rates Drop For Second Consecutive Week

Spectris Commences Third Tranche Of Share Repurchase Programme

Sandoz Gets FDA Approval For Biosimilar Hyrimoz High-concentration Formulation

Shoe Carnival Q4 GAAP Net Income Rises

TUI Group To Increase Capital By EUR 1.8 Bln To Repay Debt, Cut Costs

Death Toll Linked To Contaminated Eye Drops Rises To Three

Semtech Enters Into Cooperation Agreement With Lion Point Capital - Quick Facts

Accenture plc Q2 Profit Decreases, but beats estimates

Bytes Technology Sees Higher FY23 Results; Stock Up

TELUS Prices $500mln Of Senior Unsecured Notes With 10-year Maturity

Gambling.com Q4 Earnings - Update